Hookipa Biotech Gmbh
Clinical trials sponsored by Hookipa Biotech Gmbh, explained in plain language.
-
Experimental HIV vaccine therapy enters human testing
Disease control TerminatedThis early-stage study tested the safety of a new two-part vaccine therapy designed to train the immune system to recognize and fight HIV. The trial involved 30 adults with HIV who were already on stable medication that kept their virus levels very low. Participants received inje…
Phase: PHASE1 • Sponsor: Hookipa Biotech GmbH • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Early test of cancer Drug's immune effects halted
Knowledge-focused TerminatedThis early study aimed to see how a single dose of an experimental drug called HB-201 affects the immune system in people with HPV 16+ head/neck or cervical cancer. It was given to 10 participants in the short window between their cancer diagnosis and their scheduled surgery or c…
Phase: EARLY_PHASE1 • Sponsor: Hookipa Biotech GmbH • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:43 UTC